Lead Financial S (531288)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trades near book value: price ₹14.70 versus book value ₹14.66, giving a P/B of 1.00.
• Market cap of just ₹5 crore leaves room for special-situation asset unlocking if a corporate action occurs.
• ROCE of 4.67% is positive, suggesting some capital is still employed rather than being completely idle.
• The stock is listed and observable with a defined 52-week range, allowing price monitoring.

Concerns

• Latest quarter shows sales of ₹0 crore and net profit of ₹0 crore, indicating the business is dormant.
• Profit growth is -57.14% and sales growth is -6.25%, showing sustained contraction.
• Piotroski F-Score of 3/9 points to weak financial health and poor operational fundamentals.
• Promoter holding and debt/equity data are unavailable, leaving governance and leverage risks unquantifiable.

AI Analysis

When I evaluate Lead Financial, I begin with the same question I ask of any business: what are the owner earnings? The answer is discouraging. This NBFC has a market capitalization of just ₹5 crore, yet its latest quarter shows sales of ₹0 crore and net profit of ₹0 crore. Over the year, sales are down 6.25% and profit is down 57.14%. This is a business moving backward, not forward. Graham taught me to demand a margin of safety. The stock trades at ₹14.70 against a book value of ₹14.66, so price-to-book is 1.00. The P/E of 47.23 is meaningless at this earnings level. On paper, the asset backing appears to support the price. But book value is only protection if the assets are worth what the books claim. For an NBFC, that means a loan book that repays and no hidden bad debt. The Piotroski F-Score of 3 out of 9 warns that the financial health is weak. ROE is -0.83%, meaning shareholders' equity is being shrunk, not compounded. ROCE of 4.67% is less than what a bank fixed deposit can earn, so capital is not being deployed to good use. There is no dividend, so I get paid nothing while I wait. This is not a wonderful company at a fair price. It is a stagnant asset at a fair price. Buffett has written that time is the friend of the wonderful business and the enemy of the mediocre. With zero current earnings and declining operations, this is not a compounding machine. The only rational reason to own it is to realize the stated book value, through either a turnaround or a liquidation. That makes it an asset play, not a franchise. I would need far more proof of clean loans, honest management, and a credible plan before investing. Until then, I prefer to sit out.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer